View Author
patient cancer tumor breast level breast cancer factor analysis status tamoxifen response bcar 1 protein therapy prognostic treatment model pai -2 plasminogen bcar 1 levels receptor activator system urokinase-type plasminogen activator group study growth value multivariate month table adjuvant menopausal status upa system prognosis vegf levels chemotherapy mutation result urokinase 0.0001 nodal status tamoxifen therapy prognostic value breast cancer patients disease tumor levels growth factor multivariate analysis expression runx 2 gene tamoxifen treatment inhibitor association tissue prognostic factors angiogenesi relationship cleidocranial dysplasia cytosol menopausal nodal survival node-positive patients point base model urokinase system first-line urokinase-type variable relapse cleidocranial pai -2 levels dysplasia van putten wlj deletion postmenopausal foeken tumor size breast tumors
5 Most Recent Publications
|
Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia
(Article)
Ott, C.E. Leschik, G. Lane, A. Lee-Kirsch, M.A. Morlot, S. Simon, M.E.H. Steichen-Gersdorf, E. Tegay, D.H. Peters, H.A. Mundlos, S. Klopocki, E. Trotier, F. Brueton, L. Brunner, H, Brussel, W. Guillen-Navarro, E. Haase, C. Kohlhase, J. Kotzot, D. |
2010-08-01
|
|
The prognostic value of BCAR1 in patients with primary breast cancer.
(Article)
Dorssers, L.C.J. Grebenchtchikov, N. Tienoven, D.T. van Geurts-Moespot, A. Span, P.N. Foekens, J.A. Sweep, F.C. Brinkman, A. Look, M.P. Broekhoven, S.P. van Jong, D. de Peters, H.A. Portengen, H. Meijer van Gelder, M.E. Klijn, J.G.M. |
2004-09-15
|
|
Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease.
(Article)
Meijer van Gelder, M.E. Look, M.P. Peters, H.A. Schmidt, M. Brunner, N. Harbeck, N. Klijn, J.G.M. Foekens, J.A. |
2004-07-01
|
|
High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer
(Article)
Foekens, J.A. Peters, H.A. Grebenchtchikov, N. Look, M.P. Meijer van Gelder, M.E. Geurts-Moespot, A. Kwast, Th.H. van der Sweep, C.G. Klijn, J.G.M. |
2001-01-01
|
|
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
(Article)
Foekens, J.A. Henzen-Logmans, S.C. Janicke, F. Meijer van Gelder, M.E. Klijn, J.G.M. Putten, W.L.J. van Peters, H.A. Look, M.P. Portengen, H. Schmitt, M. Kramer, M.D. Brunner, N. |
2000-01-01
|
